ALSO NOTED: Vaccination campaign wipes out Ugandan meningitis; New strep vaccine in the works; and much more...

Vaccine Market

A vaccination campaign in Uganda has wiped out a dangerous type of childhood Meningitis in just five years. Report

And WHO says a new, low cost meningitis vaccine could be used soon to eliminate future outbreaks. Report

Lawmakers in Wales are accusing the government of leaving the area vulnerable to a shortage of bluetongue vaccine needed to treat local cows. Report

Express and Express FP modified live IBR, BVD Types 1 and 2, PI3 and BRSV vaccines, have received USDA approval for use in whole-herd vaccination programs. Release

Vaccine Research

A team of researchers at UC San Diego have shed new light on the M1 protein, which plays a key role in the development of strep. Their work may pave the way to a new vaccine for strep. Report

A novel aerosol version of the most common tuberculosis vaccine, administered directly to the lungs as an oral mist, offers significantly better protection against the disease in experimental animals than a comparable dose of the traditional injected vaccine, researchers report this week in the Proceedings of the National Academy of Sciences. Release

Crucell has been touting its vaccines business and a pipeline of new products. Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.